<DOC>
	<DOC>NCT01786798</DOC>
	<brief_summary>The objective of this study is to investigate the role of transvaginal ultrasound in detecting endometrial hyperplasia and endometrial cancer in women aged more than 35 presenting with abnormal uterine bleeding.</brief_summary>
	<brief_title>Transvaginal Ultrasound in Women With Abnormal Uterine Bleeding</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Uterine Hemorrhage</mesh_term>
	<criteria>Premenopausal women aged over than 35 Abnormal uterine bleeding (menorrhagia/menometrorrhagia/metrorrhagia) Accept transvaginal examination (pelvic examination and ultrasound) Informed consent Severe uterine bleeding resulting in unstable vital signs Pregnancy Current medications: anticoagulants, selective serotonin reuptake inhibitor (SSRI), antipsychotics, corticosteroids, hormones, herbs Intrauterine device Genital tract pathologies: infection, submucous myoma distorting uterine cavity Systemic diseases that may cause coagulopathies: Thyroid disease, liver disease, pituitary/ hypothalamus diseases Not able to retrieve endometrial tissue</criteria>
	<gender>Female</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Transvaginal sonography</keyword>
	<keyword>Endometrial thickness</keyword>
	<keyword>Endometrial pattern</keyword>
	<keyword>Abnormal uterine bleeding</keyword>
	<keyword>Endometrial hyperplasia</keyword>
	<keyword>Endometrial cancer</keyword>
</DOC>